opioid prescribers

Published on:
Friday, November 22, 2013

The FDA has required long-term evaluations of the ER/LA prescribers who complete REMS-compliant CE activities. Specifically, the FDA is requiring the evaluation of knowledge retention and practice change in ER/LA opioid prescribers...

FDA REMS Meetings, Fact Sheet for CME Providers

The ACCME has participated in two meetings with the Food and Drug Administration (FDA) about Risk Evaluation and Mitigation Strategies (REMS). We...